Teri Klein Explained

Teri E. Klein
Fields:Pharmacogenomics
Workplaces:Stanford University
Alma Mater:University of California, Santa Cruz
UCSF
Thesis Title:KARMA, a knowledge-based system for receptor mapping
Thesis Url:https://www.worldcat.org/oclc/1020060921
Thesis Year:1987
Doctoral Advisors:)-->
Awards:Fellow of the American College of Medical Informatics (2001)[1]
Fellow of the American Association for the Advancement of Science (2021)[2]
Spouses:)-->
Partners:)-->

Teri E. Klein is an American professor of Biomedical Data Science and Medicine (and of Genetics, by courtesy) at Stanford University. She is known for her work on pharmacogenomics and computational biology.

Education

Klein has a B.A. from the University of California, Santa Cruz (1980) and a Ph.D. from the University of California, San Francisco (1987). In 2000 she started a position at Stanford University where, as of 2022, she holds the position of professor (research).[3]

She is a co-founder of the Pacific Symposium on Biocomputing and is a Principal Investigator for PharmGKB, Clinical Pharmacogenomics Implementation Consortium (CPIC), The Pharmacogenomic Clinical Annotation Tool (PharmCAT), and Clinical Genome Resource (ClinGen).[4]

Selected publications

Awards and honors

Klein was named a fellow of the American College of Medical Informatics in 2001.[5] In 2021, she was named a fellow of the American Association for the Advancement of Science.[2]

External links

Notes and References

  1. Web site: Teri E. Klein, PhD, Fellow of the American College of Medical Informatics.
  2. Web site: 2021 AAAS Fellows.
  3. Web site: Teri Klein . 2022-10-26 . www.ncbi.nlm.nih.gov.
  4. Web site: October 5, 2021 . Stanford awarded NIH funding to support ClinGen efforts in pharmacogenomics, autoimmune diseases, and ancestry and diversity in genetic research . 2022-03-29.
  5. Web site: Fellows of ACMI . 2022-10-26 . AMIA - American Medical Informatics Association . en.